搜尋結果
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal· 10 分鐘前, one of the world’s largest makers of generic drugs, has been in the penalty box with investors for years. The crisis of ...
13. Notion
CNBC· 1 小時前There is no shortage of work productivity and management tools available today, but few have the enthusiastic user base ...
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Reuters· 5 日前Indian generic drugmaker Alembic Pharma reported a 17% rise in fourth-quarter profit on ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 5 日前, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months ...
Why build a tech mafia when you can just build each other?
TechCrunch· 2 日前Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the ...
Edwards Lifesciences hit with Meril's EU antitrust complaint
Reuters· 21 小時前, opens new tab has been hit with an EU antitrust complaint by Indian rival Meril including for allegedly anti-competitive ...
Securitization limbers up for the oddball Olympics
Reuters· 6 日前Securitization might sound exotic. The idea of pooling millions of IOUs like car loans and ...
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters· 4 日前, opens new tab to market its blockbuster obesity treatment drugs in India, the company's ...
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 7 日前, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic ...